Lv22
200 积分 2022-04-19 加入
Biomarkers vs Machines: The Race to Predict Acute Kidney Injury
29天前
已完结
Implications of the Use of Artificial Intelligence Predictive Models in Health Care Settings
29天前
已完结
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
1个月前
已完结
In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events
1个月前
已完结
Efficacy and safety of telitacicept in IgA nephropathy: A retrospective, multicenter study
1个月前
已完结
Treatment of IgA Nephropathy: A Rapidly Evolving Field
1个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1个月前
已完结
Targeted release of budesonide in primary IgA nephropathy
1个月前
已完结
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS
1个月前
已完结
Targeting APRIL to slow progression of IgA nephropathy
1个月前
已完结
皖公网安备34019202002308
